Structure Therapeutics Inc. Contracts & Agreements
41 Contracts & Agreements
- Business Finance (6 contracts)
- Business Operations (7)
- Human Resources (19)
- Real Estate (1)
- Uncategorized (8)
- Offer Letter, dated September 7, 2024, by and between the Registrant and Ashley Hall (Filed With SEC on November 13, 2024)
- Offer Letter, dated September 12, 2024, by and between the Registrant and Blai Coll (Filed With SEC on November 13, 2024)
- Separation and Consulting Agreement, dated September 12, 2024, by and between the Registrant and Mark Bach (Filed With SEC on November 13, 2024)
- Amended Non-Employee Director Compensation Policy (Filed With SEC on May 9, 2024)
- Executive Employment Agreement, dated July 22, 2022, by and between the registrant and Xichen Lin (Filed With SEC on May 9, 2024)
- Collaboration Agreement, dated November 7, 2023, by and between Schrdinger, Inc. and Aconcagua Bio, Inc (Filed With SEC on November 14, 2023)
- Amended Non-Employee Director Compensation Policy (Filed With SEC on August 4, 2023)
- Exchange Agreement dated May 10, 2023 between the registrant and the investors named therein (Filed With SEC on May 11, 2023)
- Summary of Rights of Non-Voting Ordinary Shares (Filed With SEC on May 11, 2023)
- Structure Therapeutics Inc. 2023 Employee Share Purchase Plan (Filed With SEC on March 30, 2023)
- Description of Securities (Filed With SEC on March 30, 2023)
- Structure Therapeutics Inc. 2023 Equity Incentive Plan (Filed With SEC on March 30, 2023)
- Form of Deposit Agreement between the registrant and JPMorgan Chase Bank, N.A., as depositary (Filed With SEC on January 30, 2023)
- Registrants Specimen Certificate for Ordinary Shares (Filed With SEC on January 30, 2023)
- Form of Underwriting Agreement (Filed With SEC on January 30, 2023)
- Board Service Agreement by and between the registrant and Joanne Waldstreicher, dated November 23, 2022 (Filed With SEC on January 12, 2023)
- Shanghai Premises Lease Contract, by and between Shanghai ShouTi Biotechnology Co., Ltd. and Shanghai Changtai Business Management Co., Ltd., dated June 22, 2021 (Filed With SEC on January 12, 2023)
- Collaboration Agreement, by and between Lhotse Bio, Inc. and Schrdinger, LLC, dated October 9, 2020 (Filed With SEC on January 12, 2023)
- Severance and Change in Control Plan (Filed With SEC on January 12, 2023)
- Non-Employee Director Compensation Policy (Filed With SEC on January 12, 2023)
- Board Service Agreement by and between the registrant and Eric Dobmeier, dated December 13 (Filed With SEC on January 12, 2023)
- Executive Employment Agreement, by and between the registrant and Raymond Stevens, dated May 16, 2019 (Filed With SEC on January 12, 2023)
- Form of Indemnification Agreement between the registrant and each of its executive officers and directors (Filed With SEC on January 12, 2023)
- ShouTi Inc. 2019 Equity Incentive Plan, as amended (including Forms of Option Grant Notice, Option Agreement and Notice of Exercise thereunder) (Filed With SEC on January 12, 2023)
- Structure Therapeutics Inc. 2023 Equity Incentive Plan (Filed With SEC on January 12, 2023)
- Form of Share Option Grant Notice, Share Option Agreement and Notice of Exercise (US) under the Structure Therapeutics Inc. 2023 Equity Incentive Plan (Filed With SEC on January 12, 2023)
- Form of Share Option Grant Notice, Share Option Agreement and Notice of Exercise (Non-Employee Director) under the Structure Therapeutics Inc. 2023 Equity Incentive Plan (Filed With SEC on January 12, 2023)
- Form of Share Option Grant Notice, Share Option Agreement and Notice of Exercise (PRC) under the Structure Therapeutics Inc. 2023 Equity Incentive Plan (Filed With SEC on January 12, 2023)
- Form of Restricted Share Unit Award Grant Notice and Award Agreement (US) under the Structure Therapeutics Inc. 2023 Equity Incentive Plan (Filed With SEC on January 12, 2023)
- Form of Restricted Share Unit Award Grant Notice and Award Agreement (PRC) under the Structure Therapeutics Inc. 2023 Equity Incentive Plan (Filed With SEC on January 12, 2023)
- Structure Therapeutics Inc. 2023 Employee Share Purchase Plan (Filed With SEC on January 12, 2023)
- Amended and Restated Investors Rights Agreement, dated July 30, 2021, by and between the registrant and the investors named therein (Filed With SEC on January 12, 2023)
- Executive Employment Agreement by and between the registrant and Jun Yoon, dated May 1 (Filed With SEC on January 12, 2023)
- Amendment to the Executive Employment Agreement by and between the registrant and Jun Yoon (Filed With SEC on January 12, 2023)
- Offer Letter, by and between the registrant and Mark Bach, M.D., dated April 19, 2021 (Filed With SEC on January 12, 2023)
- Offer Letter, by and between the registrant and Melita Sun Jung, dated April 23, 2021 (Filed With SEC on January 12, 2023)
- Employment Contract, by and between Shanghai ShouTi Biotechnology Co., Ltd. and Xichen Lin, dated July 22, 2019 (Filed With SEC on January 12, 2023)
- Employment Contract, by and between Shanghai ShouTi Biotechnology Co., Ltd. and Yingli Ma, dated November 1, 2022 (Filed With SEC on January 12, 2023)
- Supplemental Agreement, by and among Shanghai Basecamp Biotechnology Co., Ltd., Shanghai ShouTi Biotechnology Co., Ltd. and Yingli Ma, dated October 31, 2022 (Filed With SEC on January 12, 2023)
- Board Service Agreement by and between the registrant and Daniel Welch, dated December 10 (Filed With SEC on January 12, 2023)
- Board Service Agreement by and between the registrant and Sharon Tetlow, dated March 2 (Filed With SEC on January 12, 2023)
